Biocon executive chairperson Kiran Mazumdar-Shaw tests COVID-19 positive

First Published 18, Aug 2020, 10:36 AM

Biocon's Kiran Mazumdar Shaw tweeted stating, "I have added to the Covid count by testing positive..."
 

<p>Executive chairperson of Bengaluru-headquartered Biocon Ltd Kiran Mazumdar-Shaw tested positive for coronavirus on August 17.&nbsp;</p>

Executive chairperson of Bengaluru-headquartered Biocon Ltd Kiran Mazumdar-Shaw tested positive for coronavirus on August 17. 

<p>She took to Twitter to announce the news stating, "I have added to the covid count by testing positive. Mild symptoms and I hope it stays that way."</p>

She took to Twitter to announce the news stating, "I have added to the covid count by testing positive. Mild symptoms and I hope it stays that way."

<p><br />
The 67-year-old biotechnology industry veteran received hundreds of get-well-soon messages after she posted the tweet.<br />
&nbsp;</p>


The 67-year-old biotechnology industry veteran received hundreds of get-well-soon messages after she posted the tweet.
 

<p><br />
In the state, chief minister BS Yediyurappa, Leader of Opposition Siddaramaiah and state Health Minister B Sriramulu have recovered from COVID-19.</p>


In the state, chief minister BS Yediyurappa, Leader of Opposition Siddaramaiah and state Health Minister B Sriramulu have recovered from COVID-19.

<p><br />
According to reports, Bengaluru Urban district has the biggest number of coronavirus cases in Karnataka with over 91,000 cases.</p>


According to reports, Bengaluru Urban district has the biggest number of coronavirus cases in Karnataka with over 91,000 cases.

<p><br />
&nbsp;</p>

<p>Biocon is one of the companies looking to develop a vaccine to fight COVID-19. In July, regulator the Drug Controller General of India (DCGI) allowed it to market a repurposed injection, Itolizumab, which was originally launched in 2013 for treating chronic plaque psoriasis.</p>


 

Biocon is one of the companies looking to develop a vaccine to fight COVID-19. In July, regulator the Drug Controller General of India (DCGI) allowed it to market a repurposed injection, Itolizumab, which was originally launched in 2013 for treating chronic plaque psoriasis.

loader